Clinical Trial Update: A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing GZR102 Injection with GZR18 Injection for Type 2 Diabetes Mellitus; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR102 Injection
• GZR18 Injection

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Status: ACTIVE_NOT_RECRUITING